By proceeding, you agree to our Terms of Use and Privacy Policy.
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
Explore identification & validation of novel targets including RNA based targets, animal and disease modelling, organoid based discovery.
Discover computational drug design – AI & automation, hit finding technologies and advancements and molecular drug design and medicinal chemistry.
Engage and connect with experts like Andreas Brunschweiger, Andrew Pannifer, Argyrides Argyrou, Colin O’Dowd and Elad Katz.
Oxford Global exists to accelerate progress in the healthcare and pharma industry by connecting the right people around the most important issues.
Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics.
Best in class in vitro models to accurately predict in vivo outcomes.
Causaly accelerates how humans acquire knowledge and develop insights in Biomedicine.
Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with premium quality tailor-made services to drug discovery in the area of ADME-Tox. The service offering is widely spread.
Apex Molecular is a leading UK based Chemistry Services Contract Research Organisation based at Alderley Park, providing specialist chemistry services to the pharmaceutical, biotechnology and applied chemistry sectors.
ChemPass was founded to develop AI-assisted technologies for explorations in synthesizable chemical space.
Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery.
Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery.
Soneas Chemicals Ltd., (UQUIFA Group member) is a chemical service provider with a pragmatic approach to innovation.
Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug-discovery and development challenges.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.